Elevations in sCD40L have been associated with pulmonary arterial hypertension (PAH) (41), while IL-2 can induce pulmonary microvasculature injury and generate an asthma-like bronchoconstriction (42). Here, IL2 is linked to pulmonary arterial hypertension.